Quentis Therapeutics

About

Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases.

New York,New York,United States
11 - 50

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $48M
Industries: Biotechnology,Health Care,Therapeutics
Founded date: Jan 1, 2016
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Quentis Therapeutics, Inc.
Also Known As: Quentis

Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases. The company's therapeutics are designed to target ER stress pathways and awaken the immune system's ability to fight cancer, enabling patients to get access to new treatments for cancer.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

2

$49M

Quentis Therapeutics has raised a total of $49M in funding over 2 rounds. Their latest funding was raised on Dec 3, 2018 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 3, 2018	Grant	$1M	1	New York City Economic Development Corporation - NYCEDC	—	Detail
Feb 27, 2018	Series A	$48M	7	Polaris Partners Versant Ventures	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

8

Quentis Therapeutics is funded by 8 investors. New York City Economic Development Corporation - NYCEDC and Polaris Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
New York City Economic Development Corporation - NYCEDC	Yes	Grant
Polaris Partners	Yes	Series A
Versant Ventures	Yes	Series A
AbbVie Biotech Ventures	—	Series A
Alexandria Venture Investments	—	Series A
New York Ventures	—	Series A
Taiho Pharmaceutical Co	—	Series A
Yonghua Capital	—	Series A